Literature DB >> 2420628

Angiogenic activity of the corneal epithelium.

J A Eliason.   

Abstract

A homogenate of corneal epithelial cells was tested to determine if it could induce vascularization in the cornea. Both fresh and cultured cells were used as sources of the homogenate which was evaluated in vivo using a self-contained system to perfuse it constantly into the corneal stroma. A vigorous growth of vessels resulted when the concentration of the homogenate exceeded a threshold of 20 micrograms per ml total protein. This capacity was not destroyed when the homogenate was heated. As a preliminary refinement of this response white blood cells were eliminated from the model with whole body X-irradiation. Vascularization occurred in leukopenic animals but was less than that observed in normal animals. It is concluded that the epithelial homogenate is able to provoke corneal vascularization in the absence of leukocytes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2420628     DOI: 10.1016/0014-4835(85)90180-0

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  4 in total

1.  Laser photocoagulation for corneal stromal vascularization.

Authors:  V S Nirankari
Journal:  Trans Am Ophthalmol Soc       Date:  1992

2.  Direct stimulation of limbal microvessel endothelial cell proliferation and capillary formation in vitro by a corneal-derived eicosanoid.

Authors:  R A Stoltz; M S Conners; M E Gerritsen; N G Abraham; M Laniado-Schwartzman
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

3.  Role of protein tyrosine phosphorylation in rat corneal neovascularization.

Authors:  A Hayashi; K S Popovich; H C Kim; E de Juan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-07       Impact factor: 3.117

4.  Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).

Authors:  Dimitri T Azar
Journal:  Trans Am Ophthalmol Soc       Date:  2006
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.